GEn1E Lifesciences Inc.

📍 Palo Alto, United States🗓 Founded 2018👥 11 employees💰 Last funded Dec 2021
Biotechnology Research🌐 gen1e.com
Website LinkedIn
GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. They develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments. GEn1E is supercharging the drug development cycle by applying AI to multiple-mechanism-of-action protein targets and their natural platform capabilities—creating novel therapeutics at an unprecedented pace. Their AI platform has enabled them to develop a purpose-built therapy for ARDS to reduce its $20 billion cost on society (just in the USA). GEn1E has built a rich pipeline of 21+ novel and selective immunomodulators and has plans to accelerate 2 additional devastating diseases (beyond their lead indication) to IND in the next 12 months. Their AI platform enables tremendous pace and capital efficiency as demonstrated by their progress in ~2 years with seed capital—a stark contrast to the typical spend of $100M+ and 7+ years exhibited in the pharmaceuticals / biotech industry. With ~90% of rare diseases having no therapeutic treatment at all, GEn1E is taking a giant swing that will hopefully bring life-saving therapies to the lives of patients in need. GEn1E’s team has decades of experience in drug development and machine learning, and they graduated from YCombinator and Stanford-StartX in late 2019. GEn1E is based in Palo Alto, CA.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Brazil
1
Investor activity2020–2021 · investors recorded per year
2020320211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in GEn1E Lifesciences Inc.?
GEn1E Lifesciences Inc. has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did GEn1E Lifesciences Inc. last raise funding?
The most recent investment in GEn1E Lifesciences Inc. recorded on gritt.io was in December 2021.
When was GEn1E Lifesciences Inc. founded?
GEn1E Lifesciences Inc. was founded in 2018.
What industry is GEn1E Lifesciences Inc. in?
GEn1E Lifesciences Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GEn1E Lifesciences Inc. based?
GEn1E Lifesciences Inc. is headquartered in Palo Alto, United States.